225 related articles for article (PubMed ID: 32187960)
21. Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models.
Guse K; Sloniecka M; Diaconu I; Ottolino-Perry K; Tang N; Ng C; Le Boeuf F; Bell JC; McCart JA; Ristimäki A; Pesonen S; Cerullo V; Hemminki A
J Virol; 2010 Jan; 84(2):856-66. PubMed ID: 19906926
[TBL] [Abstract][Full Text] [Related]
22. A cancer-favoring oncolytic vaccinia virus shows enhanced suppression of stem-cell like colon cancer.
Yoo SY; Bang SY; Jeong SN; Kang DH; Heo J
Oncotarget; 2016 Mar; 7(13):16479-89. PubMed ID: 26918725
[TBL] [Abstract][Full Text] [Related]
23. Reovirus as a viable therapeutic option for the treatment of multiple myeloma.
Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
Clin Cancer Res; 2012 Sep; 18(18):4962-72. PubMed ID: 22761466
[TBL] [Abstract][Full Text] [Related]
24. Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virus.
Peng J; Wang S; Fan W; Li S; Wu Y; Mou X; Wang J; Tong X
Onco Targets Ther; 2018; 11():6887-6900. PubMed ID: 30410347
[TBL] [Abstract][Full Text] [Related]
25. Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8
Wei W; Tian L; Zheng X; Zhong L; Chen Y; Dong H; Zhang G; Wang S; Tong X
Oncoimmunology; 2024; 13(1):2322173. PubMed ID: 38419758
[TBL] [Abstract][Full Text] [Related]
26. Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL-24 gene in liver cancer cells.
Wang C; Li Q; Xiao B; Fang H; Huang B; Huang F; Wang Y
J Clin Lab Anal; 2021 Mar; 35(3):e23677. PubMed ID: 33274495
[TBL] [Abstract][Full Text] [Related]
27. IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer.
Deng L; Yang X; Fan J; Ding Y; Peng Y; Xu D; Huang B; Hu Z
Oncol Res; 2021 Mar; 28(6):579-590. PubMed ID: 32641200
[TBL] [Abstract][Full Text] [Related]
28. Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancer.
Huang J; Ji L; Si J; Yang X; Luo Y; Zheng X; Ye L; Li Y; Wang S; Ge T; Tong X; Cai Y; Mou X
J Colloid Interface Sci; 2024 Oct; 671():216-231. PubMed ID: 38801796
[TBL] [Abstract][Full Text] [Related]
29. Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models.
Cecil A; Gentschev I; Adelfinger M; Dandekar T; Szalay AA
Bioengineered; 2019 Dec; 10(1):190-196. PubMed ID: 31142183
[TBL] [Abstract][Full Text] [Related]
30. A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer.
Chard LS; Maniati E; Wang P; Zhang Z; Gao D; Wang J; Cao F; Ahmed J; El Khouri M; Hughes J; Wang S; Li X; Denes B; Fodor I; Hagemann T; Lemoine NR; Wang Y
Clin Cancer Res; 2015 Jan; 21(2):405-16. PubMed ID: 25416195
[TBL] [Abstract][Full Text] [Related]
31. Combing oncolytic adenovirus expressing Beclin-1 with chemotherapy agent doxorubicin synergistically enhances cytotoxicity in human CML cells in vitro.
Li L; You LS; Mao LP; Jin SH; Chen XH; Qian WB
Acta Pharmacol Sin; 2018 Feb; 39(2):251-260. PubMed ID: 28905936
[TBL] [Abstract][Full Text] [Related]
32. Oncolytic cancer therapy with a vaccinia virus strain.
Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B; Hu Z
Oncol Rep; 2019 Jan; 41(1):686-692. PubMed ID: 30365140
[TBL] [Abstract][Full Text] [Related]
33. Oncolytic Vaccinia Virus Expressing
Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
[TBL] [Abstract][Full Text] [Related]
34. Vaccinia virus induces programmed necrosis in ovarian cancer cells.
Whilding LM; Archibald KM; Kulbe H; Balkwill FR; Öberg D; McNeish IA
Mol Ther; 2013 Nov; 21(11):2074-86. PubMed ID: 23985697
[TBL] [Abstract][Full Text] [Related]
35. Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma.
Deng L; Yang X; Ding Y; Fan J; Peng Y; Xu D; Huang B; Hu Z
Virol J; 2022 Mar; 19(1):44. PubMed ID: 35292065
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic
Yeşilaltay A; Muz D; Erdal B
Turk J Haematol; 2024 Mar; 41(1):16-25. PubMed ID: 38258554
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.
Gil M; Bieniasz M; Seshadri M; Fisher D; Ciesielski MJ; Chen Y; Pandey RK; Kozbor D
Br J Cancer; 2011 Nov; 105(10):1512-21. PubMed ID: 21989183
[TBL] [Abstract][Full Text] [Related]
38. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
[TBL] [Abstract][Full Text] [Related]
39. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
[TBL] [Abstract][Full Text] [Related]
40. A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer.
Gholami S; Marano A; Chen NG; Aguilar RJ; Frentzen A; Chen CH; Lou E; Fujisawa S; Eveno C; Belin L; Zanzonico P; Szalay A; Fong Y
Breast Cancer Res Treat; 2014 Dec; 148(3):489-99. PubMed ID: 25391896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
